In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AmeriNet and Hospital Consolidation's EndGame

Executive Summary

The recent consolidations among national hospital groups has left many suppliers feeling a significant loss of leverage in contract negotiations. But what hospitals don't realize is that consolidation on the supplier side, due to market attrition and increased merger and acquisitions, has created suppliers nearly invulnerable to competitive pressure. As the number of players on both sides of the table shrinks, has consolidation in hospital supply gone too far?

You may also be interested in...



Is Group Purchasing Broke?

Facing unprecedented scrutiny from major media and the US Senate, leading GPOs are beginning to revamp their policies to address concerns on the part of small suppliers that the current system unfairly excludes them. But given the animosity between the two sides, will there ever be a meeting of the minds on GPO reform?

Is Group Purchasing Broke?

Facing unprecedented scrutiny from major media and the US Senate, leading GPOs are beginning to revamp their policies to address concerns on the part of small suppliers that the current system unfairly excludes them. But given the animosity between the two sides, will there ever be a meeting of the minds on GPO reform?

The Realpolitik of the Device Industry

After years of criticizing medical technology advances as a cause of rising healthcare costs, many health policy experts and economists are coming around to the view that technology can reduce costs. But such a positive view of technology is worthless if hospitals won't pay a reasonable price for products. A recent New York Times article blasted hospital group purchasing for blocking access to new technology. But it was wrong--the real danger is that group purchasing is destroying hospitals' access to products that already exist.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV000557

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel